首页> 外文期刊>Future microbiology >Development and validation of a triplex quantitative real-time PCR assay to detect efflux pump-mediated antibiotic resistance in Burkholderia pseudomallei
【24h】

Development and validation of a triplex quantitative real-time PCR assay to detect efflux pump-mediated antibiotic resistance in Burkholderia pseudomallei

机译:三重定量实时PCR测定检测伯克德列尔菌假型抗生素抗生素抗生素抗生素抗生素抗生素抗性的开发及验证

获取原文
获取原文并翻译 | 示例
           

摘要

Aim: To develop a probe-based triplex quantitative real-time PCR assay to simultaneously detect the upregulation of the efflux pumps AmrAB–OprA, BpeAB–OprB and BpeEF–OprC in Burkholderia pseudomallei strains exhibiting increased minimum inhibitory concentrations toward meropenem, doxycycline or trimethoprim-sulfamethoxazole. Methods: The triplex assay was developed and subsequently tested on RNA isolated from eight clinical and eight laboratory-generated B. pseudomallei mutants harboring efflux pump regulator mutations. Results: The triplex assay accurately detected efflux pump upregulation in all clinical and laboratory mutants, which corresponded with decreased antibiotic susceptibility or antibiotic resistance. Conclusion: Rapid detection of antibiotic resistance provides clinicians with a tool to identify potential treatment failure in near real time, enabling informed alteration of treatment during an infection and improved patient outcomes.
机译:目的:要开发基于探测的三重单链式实时PCR测定,同时检测伯克德列伯菌,BPEAB-OPRB和BPEEF-opRC的开关泵AMRAB-OPRC的上调,表现出对MEROPENEM,强霉素或TRIMETHOCHIM的增加最低抑制浓度 -Sulfamethoxazole。 方法:开发了三醇测定,随后在八个临床和八个实验室生成的B.Pseudomallei突变体中分离的RNA进行测试,含有Efflux泵调节器突变。 结果:在所有临床和实验室突变体中,Triplex测定精确地检测到Efflux泵上调,其与抗生素敏感性降低或抗生素抗性相对应。 结论:快速检测抗生素抗性为临床医生提供了一种近期实时识别潜在治疗失败的工具,使得在感染期间能够改变治疗和改善的患者结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号